Sigma Labs Reports First Quarter 2020 Financial Results
Back to Newsroom
Mentioned in this Article

Sigma Labs Reports First Quarter 2020 Financial Results

Thursday, May 14, 2020 4:01 PM
Share this article now

Management to Host Conference Call Today at 4:30 p.m. ET

SANTA FE, NM / ACCESSWIRE / May 14, 2020 / Sigma Labs, Inc. (NASDAQ:SGLB) ("Sigma Labs"), a leading developer of quality assurance software for the additive manufacturing industry, reported its financial and operational results for the first quarter ended March 31, 2020.

Key First Quarter 2020 and Subsequent Operational Highlights

  • Announced several key contract wins to further validate the company's technology, including:
    • Contract to implement PrintRite3D in collaboration with university research centers at the Northwestern University, Northwestern Initiative on Manufacturing Science and Innovation (NIMSI) and Center for Hierarchical Materials Design (CHiMaD).
    • Contract with the Mississippi State University Center for Advanced Vehicular Systems (CAVS), a world-class interdisciplinary research center that uses state-of-the-art technology to address engineering challenges facing U.S. mobility industries.
  • Awarded two U.S. Patents for PrinRite3D® quality assurance software:
    • U.S. Application No.: 16/234,333 Titled: Systems and Methods for Additive Manufacturing Operations; and
    • U.S. Application No.: 16/282,004 Titled: Systems and Methods for Measuring Radiated Thermal Energy During an Additive Manufacturing Operation.
  • Selected Excel3D Advanced Technologies, a provider of 3D manufacturing software as its preferred value-added reseller for sales of Sigma Labs products in India - expanding Sigma Labs' global footprint into the world's fifth-largest manufacturing economy.
  • Entered into joint sales agreement with Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and 3D printing solutions, to commercialize newly integrated PrintRite3D quality assurance technology with the Materialise control platform.
  • Launched Printrite3D® Production Series that introduces the ‘Production Dashboard' and provides production managers with critical metrics, insight and actionable information during the production process.
    • New production dashboard and AI driven metrics provide critical real-time information as 3D printing alternatives accelerate due to worldwide crisis.
  • Appointed Mark K. Ruport as President and Chief Executive Officer, from his prior position as Executive Chairman, to further drive formation of strategic relationships, growth and sales strategies as the company commercializes its proprietary PrintRite3D technology. John Rice remains non-executive Chairman of the Board and has entered into a consulting contract with the company.
  • Raised $4.1 million in gross proceeds from both a January 2020 private placement of convertible preferred stock and warrants as well as an April 2020 offering of common stock and warrants.

COVID-19 Impact to Operations:

  • Short-term disruption to purchasing plans as companies evaluate their industry's situation and approach capital expenditures with caution.
  • New remote monitoring functionality enables customers to remotely monitor a build in-process at the factory and when required take action and notify the production manager.
  • Increased efficiencies in installations and maintenance by use of advanced technologies allowing Sigma engineers to direct end users to address certain issues instead of traveling and performing services onsite.
  • Long-term, many believe that the crisis will cause companies to re-evaluate their supply chains and move the manufacturing process closer to where the part or product will be needed. Such changes, are thought by many, to accelerate the adoption of 3D printing in order to introduce more flexibility into the manufacturing process, greatly improving the ability to react to any disruption, including pandemics, political unrest, natural disasters, etc.

Management Commentary

"The first quarter of 2020, even amongst the various COVID-19 related headwinds, positioned us for an exciting year in the commercialization of PrintRite3D," said Mark K. Ruport, President and Chief Executive Officer of Sigma Labs. "Although we had some short-term impact on our business in March, we are cautiously optimistic that the momentum in the market and the increased demand for more agility in manufacturing supply chains will accelerate the growth of 3D metal printing and open up an even larger opportunity and demand for our technology. We have a well-refined product, ready for use in immediate production and validated by tier-1 partners globally.

"From a cash perspective, in response to the COVID-19 pandemic and the resulting economic uncertainties, we've reduced our cash burn by over $100,000 per month through salary reductions and deferments, lowering our COGs, as well as other actions. This will extend our cash runway and demonstrates our team's commitment to our shareholders.

"As the newly appointed CEO, my top four 2020 goals are:

  1. Increasing quarter-over quarter revenue driven by multiple independent revenue streams;
  2. Multi-unit sales of PrintRite3D Production Series by end users that have validated our technology through the RTE program, or through our current contract which allows for a 90-day evaluation;
  3. Strategic Alliances and OEM contracts with both Additive manufacturing hardware and software companies that provide sales leverage and market validation; and
  4. Continued success with R&D organizations and Universities with advanced manufacturing programs training tomorrow's manufacturing leaders on the value of a 3rd party, standards-based in-process quality assurance solution for 3D printing.

"Overall, our level of engagement with customers and prospects has been high. This is further validation that the market sees the need for our technology and that customers put a high priority on completing their evaluations and moving forward on their strategic plans to incorporate 3D printing into their manufacturing strategy,' concluded Rupert.

First Quarter 2020 Financial Results

Revenue for the first quarter of 2020 totaled $221,730. This compares to revenues of $64,450 for the first quarter of 2019. The increase in revenue was due to PrintRite3D® unit sales to two research universities, as well as revenue recognized under the legacy Rapid Test and Evaluation ("RTE") program during the quarter.

Gross profit for the first quarter of 2020 was negative $22,973. The company's first quarter 2020 gross margin is primarily a function of ongoing support of legacy RTE programs, including equipment upgrades and additional travel and labor costs.

Total operating expenses for the first quarter of 2020 were $1.6 million. Total operating expenses for the first quarter of 2019 totaled $1.5 million.

Cash used in operating activities for the first quarter ended March 31, 2020 totaled $1.5 million, compared to $1.1 million in the first quarter ended March 31, 2019. This was unusually high due to trade accounts payables carried over from 2019 due to a delay in financing and is not representative of what management expects going forward.

Net loss for the first quarter of 2020 was $1.6 million, or $(1.30) per share, as compared to a net loss of $1.5 million, or $(1.60) per share, in the first quarter of 2019.

Cash totaled $0.6 million at March 31, 2020, as compared to $0.1 million at December 31, 2019 and $1.9 million at March 31, 2019. Subsequent to the close of the first quarter of 2020, the Company completed a $1.5 million offering to further fortify its balance sheet.

First Quarter 2020 Results Conference Call

Sigma Labs President and CEO Mark Ruport and CFO Frank Orzechowski will host the conference call, followed by a question and answer period.

To access the call, please use the following information:


Thursday, May 14, 2020


4:30 p.m. Eastern time, 1:30 p.m. Pacific time

Toll-free dial-in number:


International dial-in number:


Conference ID:


Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.

The conference call will be broadcast live and available for replay at and via the investor relations section of the Company's website at

A replay of the conference call will be available after 7:30 p.m. Eastern time through May 28, 2020.

Toll-free replay number:


International replay number:


Replay ID:


About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D® for 3D advanced manufacturing technologies. Sigma Labs' advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors, including, but not limited to, the uncertain effect of the COVID-19 pandemic on the Company's business, results of operations and financial condition, which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K (including but not limited to the discussion under "Risk Factors" therein) filed with the SEC on March 24, 2020 and which may be viewed at

Investor Contact:

Chris Tyson
Managing Director
MZ Group - MZ North America
[email protected]

Sigma Labs, Inc.
Condensed Balance Sheets

  March 31,
    December 31, 2019  
Current Assets:
  631,018     86,919  
Accounts Receivable, net
    119,425       55,540  
    505,803       598,718  
Prepaid Assets
    136,721       199,727  
Total Current Assets
    1,392,967       940,904  
Other Assets:
Property and Equipment, net
    128,527       128,723  
Intangible Assets, net
    602,054       569,341  
Investment in Joint Venture
    500       500  
Long-Term Prepaid Asset
    52,000       52,000  
Total Other Assets
    783,081       750,564  
  2,176,048     1,691,468  
Current Liabilities:
Accounts Payable
  484,114     727,114  
Notes Payable
    -       50,000  
Deferred Revenue
    94,118       139,447  
Accrued Expenses
    165,040       122,658  
Total Current Liabilities
    743,272       1,039,219  
    743,272       1,039,219  
Commitments & Contingencies
Stockholders' Equity
Preferred Stock, $0.001 par; 10,000,000 shares authorized; 1,378 and 0 issued and outstanding, respectively
    2       -  
Common Stock, $0.001 par; 8,000,000 shares authorized; 1,817,834, and 1,403,759 issued and outstanding, respectively
    1,818       1,404  
Additional Paid-In Capital
    29,425,382       26,746,439  
Accumulated Deficit
    (27,994,426 )     (26,095,594 )
Total Stockholders' Equity
    1,432,776       652,249  
  2,176,048     1,691,468  

Sigma Labs, Inc.
Condensed Statements of Operations

  Three Months Ended  
  March 31, 2020     March 31, 2019  
  221,730     64,450  
    244,703       96,555  
    (22,973)       (32,105)  
Salaries & Benefits
    652,197       512,560  
Stock-Based Compensation
    154,171       254,206  
Operating R&D Costs
    53,689       145,272  
Investor & Public Relations
    238,268       157,789  
Legal & Professional Service Fees
    211,509       184,570  
Office Expenses
    147,747       166,110  
Depreciation & Amortization
    18,012       48,383  
Other Operating Expenses
    84,049       38,209  
Total Operating Expenses
    1,559,642       1,507,098  
    (1,582,615)       (1,539,203)  
Interest Income
    851       5,782  
State Incentives
    -       51,877  
Exchange Rate Loss
    (1,391 )     (446 )
Interest Expense
    (431 )     (2,122 )
Total Other Income (Expense)
    (971)       55,091  
    (1,583,585)       (1,484,112)  
Provision for Income Taxes
    -       -  
Net Loss
  (1,583,585)     (1,484,112)  
Preferred Dividends
    (315,247 )     -  
Net Loss Applicable to Common Stockholders
  (1,898,832)     (1,484,112)  
Net Loss per Common Share - Basic and Diluted
  (1.30)     (1.60)  
Weighted Average Number of Shares Outstanding - Basic and Diluted
    1,463,627       933,476  

Sigma Labs, Inc.
Condensed Statements of Cash Flows

  Three Months Ended  
  March 31, 2020     March 31, 2019  
Net Loss
  (1,583,585 )   (1,484,112 )
Adjustments to reconcile Net Loss to Net Cash used in operating activities:
Noncash Expenses:
Depreciation and Amortization
    18,012       48,383  
Stock Based Compensation
    154,170       254,206  
Securities Issued for Third Party Services
    39,618       -  
Change in assets and liabilities:
Accounts Receivable
    (63,885 )     (33,150 )
Interest Receivable
    -       (1,561 )
    92,915       (56,785 )
Prepaid Assets
    63,006       (25,187 )
Accounts Payable
    (243,000 )     288,395  
Deferred Revenue
    (45,330 )     29,825  
Accrued Expenses
    42,383       (86,783 )
    (1,525,696)       (1,066,769)  
Purchase of Property and Equipment
    (11,474 )     (1,269 )
Purchase of Intangible Assets
    (39,055 )     (74,560 )
Payment Received from Notes Receivable
    -       15,000  
    (50,529)       (60,829)  
Gross Proceeds from Public and Private Issuances of Securities
    2,100,000       1,961,220  
Less Offering Costs
    (428,876 )     (281,890 )
Payment of Note Payable
    (50,000 )     -  
Proceeds from exercise of Warrants
    499,200       75,848  
    2,120,324       1,755,178  
    544,099       627,580  
    86,919       1,279,782  
  631,018     1,907,362  
Supplemental Disclosures:
Noncash investing and financing activities disclosure:
Common Stock Issued for Cashless Exchange of UPOs
    -       88,431  
Paid-in-Kind Dividend and Common Stock Issued for Preferred Dividends
    315,247       -  
Disclosure of cash paid for:
  1,458     1,028  
Income Taxes
  -     -  

SOURCE: Sigma Labs, Inc.

Sigma Labs, Inc.
Back to Newsroom


Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions